Richard Kempson
Publication Details
-
Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial.
Menopause. 2005 Nov-Dec; (6): 716-27
The purpose of this multicenter, double-blind, randomized, parallel-group study was to determine the effect of thirteen 28-day cycles of drospirenone combined with estradiol, compared with estradiol alone, on the endometrium of postmenopausal women.
Help